World’s First Once-Weekly Insulin Arrives in India, Reducing Diabetes Injection Burden
For people living with diabetes, this is a significant development because insulin therapy is often associated with routine disruption, injection fatigue and hesitation around long-term use. A daily basal insulin schedule means nearly 365 injections a year. Awiqli brings that down to around 52 injections annually, which could make insulin therapy easier to accept for patients who need it but delay initiation because of fear, discomfort or lifestyle concerns.